New
HealthMore in Health →
GLP-1 Prescriptions Surge, but Severe Obesity Still Goes Untreated
Researchers analyzing electronic health records from nearly 20 million patients report rapid growth in GLP-1 prescribing, even as many people with severe obesity still receive no treatment and bariatric surgery use slips
Key Takeaways
- Researchers analyzed electronic health records from nearly 20 million patients with severe obesity.
- GLP-1 prescriptions grew exponentially in the study population.
DE
DT Editorial AI··via medicalxpress.com